Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

2.

St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.

Sarris J, Fava M, Schweitzer I, Mischoulon D.

Pharmacopsychiatry. 2012 Nov;45(7):275-8. doi: 10.1055/s-0032-1306348. Epub 2012 May 16.

PMID:
22592504
3.

Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group.

Chen JA, Papakostas GI, Youn SJ, Baer L, Clain AJ, Fava M, Mischoulon D.

J Clin Psychiatry. 2011 Dec;72(12):1669-76. doi: 10.4088/JCP.10m06453. Epub 2011 Oct 4.

PMID:
22053942
4.

The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide.

Fan L, Zhou G, Guo D, Liu YL, Chen WQ, Liu ZQ, Tan ZR, Sheng D, Zhou HH, Zhang W.

Clin Pharmacokinet. 2011 Sep;50(9):605-11. doi: 10.2165/11587310-000000000-00000.

PMID:
21827215
5.

The treatment of minor depression with St. John's Wort or citalopram: failure to show benefit over placebo.

Rapaport MH, Nierenberg AA, Howland R, Dording C, Schettler PJ, Mischoulon D.

J Psychiatr Res. 2011 Jul;45(7):931-41. doi: 10.1016/j.jpsychires.2011.05.001. Epub 2011 May 31.

6.

Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.

Singer A, Schmidt M, Hauke W, Stade K.

Phytomedicine. 2011 Jun 15;18(8-9):739-42. doi: 10.1016/j.phymed.2011.02.016. Epub 2011 Apr 21.

PMID:
21514125
7.

St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.

Mannel M, Kuhn U, Schmidt U, Ploch M, Murck H.

J Psychiatr Res. 2010 Sep;44(12):760-7. doi: 10.1016/j.jpsychires.2010.01.010. Epub 2010 Feb 23.

PMID:
20181361

Supplemental Content

Loading ...
Support Center